Severe hypertriglyceridemia is typically caused by a combination of genetic and lifestyle factors. Inherited lipid metabolism disorders, such as familial hypertriglyceridemia, are a common cause. Lifestyle factors, including a diet high in fats and sugars, obesity, and excessive alcohol consumption, can also contribute.
Hypertriglyceridemia
Hightower Clinical’s past study aimed to improve understanding and introduce potential treatment options for this STHG.
About Hypertriglyceridemia Study
Severe Hypertriglyceridemia (SHTG) is a metabolic condition characterized by extremely high triglyceride levels (≥500 mg/dL), posing significant health risks such as pancreatitis and cardiovascular complications. The study explored the efficacy and safety of an investigational treatment designed to lower triglyceride levels and improve patient outcomes. By evaluating fasting serum triglyceride levels over a period of time, this research contributed valuable insights into the potential management of SHTG, bringing us closer to innovative therapeutic solutions.
Current Status
Not Recruiting
Study Count
01
Study Information
Hypertriglyceridemia Research Study
| Study Name | Protocol Number | Sponsor |
|---|---|---|
| Hypertriglyceridemia | ENTRUST BIO89-100-231 | 89bio, Inc |
Frequently Asked Questions
Why Participate in a Severe Hypertriglyceridemia Clinical Trial?
Taking part in a clinical trial can provide several potential benefits. Participants gain access to new and innovative treatments that may not yet be available to the general public. Additionally, they receive specialized care from expert physicians, with all trial-related care provided at no cost.
Unlock New Opportunities in Clinical Research - Join Today!
We're here and eager to assist. Reach out to Hightower Clinical Research in Oklahoma City, OK for further details on how we can support you.
Get Involved Today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.